Medicine. A portfolio model of drug development for tuberculosis

Science. 2006 Mar 3;311(5765):1246-7. doi: 10.1126/science.1119299.
No abstract available

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Clinical Trials as Topic / economics
  • Computer Simulation
  • Costs and Cost Analysis
  • Drug Approval* / economics
  • Drug Evaluation, Preclinical / economics
  • Drug Industry
  • Humans
  • Monte Carlo Method
  • National Institutes of Health (U.S.)
  • Private Sector
  • Probability
  • Public Sector
  • Time Factors
  • Tuberculosis / drug therapy*
  • United States

Substances

  • Antitubercular Agents